From the Laboratory to the Clinic 2024: 25 Years of Biological Therapy

This annual conference, established in 1984 is organised by an international committee of renowned Immunologists. In 2024 we celebrate the 25th anniversary of “biologicals” (monoclonal antibodies and Ig fusion proteins) being approved and entering routine use in 1998/1999, for rheumatoid arthritis and Crohn's disease as well as in HER-2 positive breast cancer.

Hosted by the Kennedy Institute of Rheumatology, the conference is designed to foster and facilitate interactions between a global audience of laboratory scientists, pharmaceutical and biotech scientists and clinicians, all interested in translational research. Over the years, the format has facilitated scientific exchange leading to new collaborations and scientific progress in the translational research space.

We look forward to welcoming you in August.

Topics

• The beginnings and impact
• Cancer and beyond
• Neuroimmune interactions
• Pioneering technology
• Protein degraders
• Future of biologics

Confirmed speakers

• Ravinder Maini, Imperial College London
• Josef Smolen, Medical University of Vienna
• Lars Klareskog, Karolinska Institutet, Stockholm
• Tadamitsu Kishimoto, Osaka University
• Tim Springer, Harvard Medical School
• Mike Shepard, Enosi Therapeutics
• Barry Coller, The Rockefeller University
• Larry Steinman, Beckman Center for Molecular Medicine Stanford University
• Rony Dahan, Weizmann Institute of Science
• Miriam Merad, Icahn School of Medicine at Mount Sinai
• Gregory Winter, Trinity College, Cambridge
• Dr Dan Capon, HingeBio
• Paul Carter, Genentech, Inc.
• Sally Ward, University of Southampton
• Jeff Ravetch, The Rockefeller University
• Nebojsa Janjic, SomaLogic
• Kevin Tracey, Feinstein Institutes for Medical Research
• Ana Domingos, University of Oxford
• Brian Kim, Icahn School of Medicine at Mount Sinai
• Fränze Progatzky, University of Oxford
• Sophie Ugolini, Marseille-Luminy Immunology Centre
• David Artis, Weill Cornell Medicine
• Asya Rolls, Israel Institute of Technology
• Tom Daniel
• Mark Rolfe, Bristol Myers Squibb
• Plus more speakers to be confirmed!

Registration Information

Registration is now open and closes on 2 August 2024. You can register through the main conference website. Please register early as places are limited.

Posters

This year we welcome you to present posters which will be displayed throughout the conference. 

Information for poster presenters can be found on the main conference website.

Prices

We are offering both in-person and virtual attendance this year.

Conference tickets range from £200 (single days) - £1100 (full conference) with discount for academic attendees. PhD students are welcome to attend and also are offered a discounted ticket price. 

Visit the main conference website for all of the available options.

Contact Information 

If you have questions about the conference please contact Charlotte at labtoclinic@kennedy.ox.ac.uk.